Company page

Actinogen Medical Limited

Actinogen Medical Limited (ASX: ACW) is an Australian public company focused on developing innovative treatments for cognitive decline and related conditions. With a market capitalization of approximately AUD 92.36 million, the company is dedicated to advancing its research and clinical programs. Actinogen aims to address significant unmet medical needs in the field of neurodegenerative diseases.